Form 4: Edwards Lifesciences Director, Leslie Stone Heisz, Reports Acquisition of Restricted Stock Units

Leslie Stone Heisz, a director at Edwards Lifesciences, reported the acquisition of 3,055 restricted stock units on May 8, 2024.

Summary

• On May 8, 2024, Leslie Stone Heisz, a director of Edwards Lifesciences Corp, acquired 3,055 shares of common stock in the form of restricted stock units.
• These restricted stock units were granted under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program.
• The restricted stock units are scheduled to vest 100% after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders.
• Following the transaction, Heisz directly owns 30,035 shares of Edwards Lifesciences common stock.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, indicating alignment between management and shareholders. This is generally viewed positively.

Positives

• The acquisition of restricted stock units aligns the director's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Future Outlook

The restricted stock units will vest after one year from the grant date or at the next annual meeting of stockholders.

Industry Context

Directors commonly receive stock-based compensation to align their interests with shareholders and incentivize long-term value creation. This Form 4 filing is a routine disclosure of such compensation.

Stakeholder Impact

• The grant of restricted stock units aligns the director's interests with those of the shareholders, potentially leading to decisions that benefit the company's long-term value.

Key Dates